Business
BD Reaches Major Milestone for Rotarex™ Catheter System with First Patient Enrolled in XTRACT™ Registry to Advance Real-World Evidence in Peripheral Artery Disease
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the enrollment of the first patient in the XTRACT™ Registry, a prospective, multi-center, single-arm, post-market registry study designed to evaluate the real-world performance of the Rotarex™ Catheter System in the treatment of patients with peripheral artery disease (PAD) lesions.
About this update from Becton, Dickinson And Company
[{"type":"text","content":"FRANKLIN LAKES, N.J., Oct. 9, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the enrollment of the first patient in the XTRACT™ Registry, a prospective, multi-center, single-arm, post-market registry study designed to evaluate the real-world performance of the Rotarex™ Catheter System in the treatment of patients with peripheral artery disease (PAD) lesions.","length":443,"tagName":"p"},{"type":"image","alt":"BD Reaches Major Milestone for Rotarex™ Catheter System with First Patient Enrolled in XTRACT™ Registry to Advance Real-World Evidence in Peripheral Artery Disease","displaySize":"","headline":null,"caption":"BD Reaches Major Milestone for Rotarex™ Catheter System with First Patient Enrolled in XTRACT™ Registry to Advance Real-World Evidence in Peripheral Artery Disease","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":179,"url":"https://media.zenfs.com/en/prnewswire.com/575dbdeff71a4723f261dac6d93660e6"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/Pj.2th7_l392JgZBKNf1eQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTMxNTtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/575dbdeff71a4723f261dac6d93660e6","width":400,"height":179}},"href":"https://mma.prnewswire.com/media/2791858/XTRACT.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"The XTRACT™ Registry is being led in partnership with Co-Principal Investigators, Dr. Prakash Krishnan, an interventional cardiologist, and Dr. Todd Berland, a vascular surgeon. The first patient was enrolled on September 29, 2025, under the care of Dr. Kousta Foteh, Chief of Vascular Surgery at Vital Heart & Vein medical practice. With patient participation, the XTRACT™ Registry will now collect valuable data to inform clinical decision-making and optimize treatment strategies for PAD.","length":500,"tagName":"p"},{"type":"text","content":""We are proud to be the first site to enroll a patient in the XTRACT™ Registry," said Dr. Foteh. "This registry will provide critical real-world evidence on the Rotarex™ Catheter System and help physicians refine treatment strategies to improve outcomes for patients with PAD. This first case is similar to what we commonly see in our clinic, where an artery is more than 70% occluded...